Alrex
Product Images NDC 16590-007

2 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Alrex (NDC 16590-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Loteprednol Etabonate (structural Formula) (0f4e4ac8 189c 477f Ba85 8261d8765d02 01)

Loteprednol Etabonate (structural Formula) (0f4e4ac8 189c 477f Ba85 8261d8765d02 01)
Chemical structure of ALREX, a corticosteroid indicated by the molecular diagram showing hydroxyl, ketone, acetate, and chloromethyl functional groups arranged on a steroid backbone.*
FDA Label Image

Alrex Opth Susp Label Image (Alrex Opth Susp Label)

Alrex Opth Susp Label Image (Alrex Opth Susp Label)
Label for ALREX ophthalmic suspension 0.2%, 5 mL bottle, distributed by STAT Rx USA LLC. The label includes the NDC 16590-007-05 and indicates the active ingredient as loteprednol etabonate 2 mg (0.2%) per mL. It is manufactured by Bausch & Lomb Inc., Tampa, FL. The label advises to see the package insert and includes caution statements as well as storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.